US health regulator finds Silvassa unit non-compliant with CGMP: Ipca Labs

The company said that since this manufacturing facility is already
under USFDA import alert and presently not doing any US business, this
will have no impact on company's current on-going business activities.
The USFDA inspection of its Piparia (Silvassa) formulations
manufacturing unit in August resulted in three observations.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/us-health-regulator-finds-silvassa-unit-non-compliant-with-cgmp-ipca-labs/articleshow/72237734.cms

Comments

Popular posts from this blog

The Scroll and the Revolution: The Dilemmas of Writing about the Jews of Cuba

MAHE Manipal Research Fellow Jobs – Biotech / Mol Bio / Microbiology Apply

The Right Tool for the Job: Foreign Policy Effectiveness and Nuclear Proliferation